Ross Osborn
Stock Analyst at Cantor Fitzgerald
(0)
# 3679
Out of 5,287 analysts
111
Total ratings
37.63%
Success rate
-0.21%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Elutia | Reiterates: Overweight | 8 8 | 2.84 | 181.69% | 10 | Mar 7, 2025 | |
Axogen | Reiterates: Overweight | 24 24 | 18.14 | 32.3% | 3 | Mar 5, 2025 | |
NeuroPace | Maintains: Overweight | 19 20 | 12.37 | 61.68% | 5 | Mar 5, 2025 | |
MiMedx Group | Reiterates: Overweight | 13 13 | 8.1 | 60.49% | 3 | Feb 27, 2025 | |
SI-BONE | Reiterates: Overweight | 25 25 | 14.83 | 68.58% | 8 | Feb 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 4 4 | 1.55 | 158.06% | 4 | Feb 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 44 44 | 35.41 | 24.26% | 5 | Jan 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 9 9 | 4.09 | 120.05% | 7 | Jan 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 8 | 4.03 | 98.51% | 5 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 9 | 5.08 | 77.17% | 1 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 21 21 | 9.32 | 125.32% | 10 | Dec 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 12 | 6.12 | 96.08% | 10 | Dec 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | 1.5 | 33.33% | 4 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 16 | 11.22 | 42.6% | 4 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 14 | 12.75 | 9.8% | 2 | Oct 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 96 | 86.09 | 11.51% | 1 | Oct 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 4 4 | 1.32 | 165.15% | 5 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 3 3 | 0.57 | 338.6% | 3 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 7 | Apr 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 4 4 | 0.09 | 3566.67% | 5 | Apr 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 5.41 | -7.58% | 2 | Mar 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Nov 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 9 | 0.8 | 976.25% | 2 | Aug 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 27 21 | n/a | n/a | 2 | Apr 22, 2022 |